| SC 13G/A | 2018-05-08 | BlackRock Inc. | MyoKardia Inc | 1,786,093 | 5.0% | EDGAR |
| SC 13G/A | 2018-02-14 | Partner Fund Management, L.P. | MyoKardia Inc | - | 3.6% | EDGAR |
| SC 13G/A | 2018-02-13 | Third Rock Ventures II, L.P. | MyoKardia Inc | 2,885,104 | 8.1% | EDGAR |
| SC 13G/A | 2018-02-13 | Sanofi | MyoKardia Inc | 4,018,899 | 11.2% | EDGAR |
| SC 13G/A | 2018-02-12 | FMR LLC | MyoKardia Inc | 4,506,577 | 12.6% | EDGAR |
| SC 13G/A | 2018-02-09 | FMR LLC | MyoKardia Inc | 2,578,756 | 7.2% | EDGAR |
| SC 13G/A | 2018-02-08 | WELLINGTON MANAGEMENT GROUP LLP | MyoKardia Inc | 3,130,761 | 8.8% | EDGAR |
| SC 13G | 2018-02-01 | BlackRock Inc. | MyoKardia Inc | 1,920,651 | 5.4% | EDGAR |
| SC 13G/A | 2017-08-10 | FMR LLC | MyoKardia Inc | 2,262,192 | 7.2% | EDGAR |
| SC 13G | 2017-04-13 | Partner Fund Management, L.P. | MyoKardia Inc | - | 5.2% | EDGAR |
| SC 13G/A | 2017-04-10 | WELLINGTON MANAGEMENT GROUP LLP | MyoKardia Inc | 3,154,734 | 10.0% | EDGAR |
| SC 13G/A | 2017-02-14 | FMR LLC | MyoKardia Inc | 3,889,770 | 12.4% | EDGAR |
| SC 13G/A | 2017-02-14 | Cormorant Asset Management, LLC | MyoKardia Inc | 1,205,383 | - | EDGAR |
| SC 13G/A | 2017-02-13 | Third Rock Ventures II, L.P. | MyoKardia Inc | 8,537,754 | 27.2% | EDGAR |
| SC 13G/A | 2017-02-09 | WELLINGTON MANAGEMENT GROUP LLP | MyoKardia Inc | 2,804,966 | 8.9% | EDGAR |
| SC 13G/A | 2017-02-09 | Sanofi | MyoKardia Inc | 3,668,899 | 11.7% | EDGAR |
| SC 13G/A | 2016-10-11 | WELLINGTON MANAGEMENT GROUP LLP | MyoKardia Inc | 3,125,078 | 10.1% | EDGAR |
| SC 13G | 2016-10-11 | Cormorant Asset Management, LLC | MyoKardia Inc | 1,339,426 | - | EDGAR |
| SC 13G/A | 2016-02-12 | FMR LLC | MyoKardia Inc | 3,936,446 | 14.6% | EDGAR |
| SC 13G | 2016-02-12 | Sanofi | MyoKardia Inc | 3,218,899 | 11.9% | EDGAR |